全膝关节置换与部分膝关节置换治疗内侧间室骨关节炎的5年随机对照试验结果
TOPKAT多中心随机对照试验纳入528例孤立性内侧间室膝骨关节炎患者,比较全膝关节置换(TKR)与部分膝关节置换(PKR)的5年结局。
要点
- 5年时TKR与PKR的OKS无显著差异,再手术和并发症发生率相似。
- 作者建议对晚期孤立性内侧间室骨关节炎考虑PKR作为首选。
核心结论
- TKR与PKR均为有效术式,5年临床结局相似,再手术和并发症发生率相近。
- 基于PKR更低费用和更好成本效果,建议PKR作为晚期孤立性内侧间室骨关节炎的首选。
研究设计与样本
- 多中心、实用性随机对照试验,在英国27个中心开展。
- 采用基于专业知识和均衡相结合的随机方法,将符合内侧PKR一般要求的孤立性内侧间室膝骨关节炎患者按1:1随机分配至PKR或TKR。
- 共评估962例患者,排除431例(121例不符合纳入标准,310例拒绝参与),最终528例随机分组。
- 主要终点为随机化后5年所有随机分组患者的牛津膝关节评分(OKS)。
主要发现
- 5年随访期间PKR组较TKR组费用低910英镑(95%CI -1503至-317)。
- PKR组结局略好、手术费用和随访医疗费用更低。
关键数值与推荐
- PKR组费用节省910英镑(95%CI -1503至-317,2017年英国价格)。
临床怎么用
- 对晚期孤立性内侧间室膝骨关节炎且符合内侧PKR一般要求的患者,PKR可作为首选术式考虑。
- TKR和PKR均可提供相似的5年临床结局,选择时可结合成本效果因素。
局限性
- 原文未报告具体局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Late-stage isolated medial knee osteoarthritis can be treated with total knee replacement (TKR) or partial knee replacement (PKR). There is high variation in treatment choice and little robust evidence to guide selection. The Total or Partial Knee Arthroplasty Trial (TOPKAT) therefore aims to assess the clinical effectiveness and cost-effectiveness of TKR versus PKR in patients with medial compartment osteoarthritis of the knee, and this represents an analysis of the main endpoints at 5 years. METHODS: Our multicentre, pragmatic randomised controlled trial was done at 27 UK sites. We used a combined expertise-based and equipoise-based approach, in which patients with isolated osteoarthritis of the medial compartment of the knee and who satisfied general requirements for a medial PKR were randomly assigned (1:1) to receive PKR or TKR by surgeons who were either expert in and willing to perform both surgeries or by a surgeon with particular expertise in the allocated procedure. The primary endpoint was the Oxford Knee Score (OKS) 5 years after randomisation in all patients assigned to groups. Health-care costs (in UK 2017 prices) and cost-effectiveness were also assessed. This trial is registered with ISRCTN (ISRCTN03013488) and ClinicalTrials.gov (NCT01352247). FINDINGS: Between Jan 18, 2010, and Sept 30, 2013, we assessed 962 patients for their eligibility, of whom 431 (45%) patients were excluded (121 [13%] patients did not meet the inclusion criteria and 310 [32%] patients declined to participate) and 528 (55%) patients were randomly assigned to groups. 94% of participants responded to the follow-up survey 5 years after their operation. At the 5-year follow-up, we found no difference in OKS between groups (mean difference 1·04, 95% CI -0·42 to 2·50; p=0·159). In our within-trial cost-effectiveness analysis, we found that PKR was more effective (0·240 additional quality-adjusted life-years, 95% CI 0·046 to 0·434) and less expensive (-£910, 95% CI -1503 to -317) than TKR during the 5 years of follow-up. This finding was a result of slightly better outcomes, lower costs of surgery, and lower follow-up health-care costs with PKR than TKR. INTERPRETATION: Both TKR and PKR are effective, offer similar clinical outcomes, and result in a similar incidence of re-operations and complications. Based on our clinical findings, and results regarding the lower costs and better cost-effectiveness with PKR during the 5-year study period, we suggest that PKR should be considered the first choice for patients with late-stage isolated medial compartment osteoarthritis. FUNDING: National Institute for Health Research Health Technology Assessment Programme.
引用
- Beard DJ, Davies LJ, Cook JA, et al. The clinical and cost-effectiveness of total versus partial knee replacement in patients with medial compartment osteoarthritis (TOPKAT): 5-year outcomes of a randomised controlled trial. Lancet. 2019. PMID: 31326135. doi:10.1016/S0140-6736(19)31281-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。